Zevra Therapeutics, Inc. (ZVRA)

9.055 +0.04 (+0.39%) USD  |  NASDAQ  |  Jan 21, 10:10
More

Zevra Therapeutics Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for ZVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Verastem, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Akebia Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade